A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy
Crossref DOI link: https://doi.org/10.1007/s10549-015-3493-1
Published Online: 2015-07-11
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Le Rhun, Emilie
Delbeuck, Xavier
Lefeuvre-Plesse, Claudia
Kramar, Andrew
Skrobala, Emilie
Pasquier, Florence
Bonneterre, Jacques
Funding for this research was provided by:
Pfizer, Astra Zeneca and Novartis
Text and Data Mining valid from 2015-07-11